Filter
417
Filtered Results: 417
Text search:
leishmaniosis
Featured
Recommendations
48
New Publications
96
Language
Document type
No document type
163
Studies & Reports
89
Guidelines
50
Strategic & Response Plan
33
Manuals
22
Videos
16
Resource Platforms
15
Fact sheets
11
Training Material
6
Situation Updates
5
Infographics
5
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
56
Latin America and the Carribbean
19
Ethiopia
16
Paraguay
13
India
13
Syria
11
Colombia
10
Africa
10
Nepal
9
Kenya
8
Bangladesh
8
Brazil
8
Middle East and North Africa
6
Western and Central Europe
6
Uganda
6
Venezuela
5
Germany
5
Congo, Democratic Republic of
5
Sudan
5
Jordan
4
Bolivia
4
Ghana
3
Nigeria
3
Niger
3
East and Southern Africa
3
Lebanon
3
Zambia
3
South Sudan
3
Iraq
3
Somalia
3
Turkey
2
Iran
2
Burkina Faso
2
Peru
2
Malawi
2
Saudi Arabia
2
South–East Asia Region
2
Eastern Europe
2
Angola
2
Ecuador
2
Pakistan
2
North Macedonia
1
Mexico
1
Sierra Leone
1
Togo
1
China
1
Rwanda
1
Cameroon
1
Albania
1
Afghanistan
1
Morocco
1
Qatar
1
Mauritania
1
Mozambique
1
Cambodia
1
Asia
1
Tanzania
1
West and Central Africa
1
North America
1
Tunisia
1
South Africa
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Chad
1
Libya
1
Indonesia
1
Liberia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
128
Clinical Guidelines
66
Public Health
40
Key Resources
18
Capacity Building
5
Women & Child Health
5
Pharmacy & Technologies
5
Toolboxes
NTDs
139
Planetary Health
24
HIV
17
Rapid Response
12
Conflict
12
Global Health Education
12
COVID-19
10
Refugee
9
Caregiver
7
TB
4
Pharmacy
3
NCDs
3
Mental Health
2
Natural Hazards
2
Zika
2
Disability
1
Cholera
1
Ebola
1
Health Financing Toolbox
1
Polio
1
AMR
1
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies ...
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most com...
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat).
Leishmaniasis is caused by protozoan parasites which are tra...
Leishmaniasis is a parasitic disease caused by the Leishmania parasite. This parasite typically lives in infected sand flies. You can contract leishmaniasis from a bite of an infected sand fly.
The sand flies that carry the parasite typically reside in tropical and subtropical environments. Fatal...
We reviewed the evidence on community-based interventions for the prevention and control of cutaneous leishmaniasis (CL). Community initiatives tailored towards awareness and mobilisation are regarded as a priority area in the Neglected Tropical Disease Roadmap 2021–2030 by the World Health Organi...
Leishmaniasis is a vector-borne disease with a wide variety of parasite species, reservoirs, and vectors involved in transmission. It is caused by different species of the protozoa Leishmania and is transmitted to animals and humans through a bite of insects in the Psychodidae family. Its presence i...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
Cutaneous leishmaniasis (CL) is a parasitic disease caused by infection with a vector-borne protozoan parasite of the genus Leishmania spp. The parasite is transmitted by the bite of an infected phlebotomine sand fly. Infection results in skin lesions which take a long time to heal and may leave per...
Leishmaniasis is a vector-borne disease with a wide variety of parasite species, reservoirs, and vectors involved in transmission. It is caused by different species of the protozoa Leishmania and is transmitted to animals and humans through a bite of insects in the Psychodidae family. Its presence i...
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It is important t...
The term leishmaniasis encompasses multiple clinical syndromes, including the cutaneous, mucosal, and visceral forms, which result from infection of macrophages in the dermis, in the naso-orpharyngeal mucosa, and throughout the reticuloendothelial system, respectively. The infection can range from a...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen and liver enlargement, and, if not treated, death. P...
Leishmaniasis is a vector-borne disease with a broad global distribution and an increasing number of recorded cases worldwide. However, it is still one of the world's most neglected diseases. Over the last decades, the disease has been found to expand geographically with a global increase of cases o...
